loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 62505 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 CHARTWELL (2)

filter

01 TABLET;ORAL (2)

filter

01 RX (2)

filter

01 DOXYCYCLINE HYCLATE (2)

filter

01 No (2)

URL Supplier Web Content
TABLET; ORAL
EQ 50MG BASE
2021-07-27
62505
DOXYCYCLINE HYCLAT...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
EQ 100MG BASE
1984-09-11
62505
DOXYCYCLINE HYCLAT...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 62505

Looking for FDA Orange Book APPLICATION 62505 2

19

Chartwell Pharmaceuticals llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 62505.

Regulatory Information RX

With a dosage strength EQ 50MG BASE

Dosage Form Route TABLET; ORAL

Reference Listed Drug No

Approved since 2021-07-27

Therapeutic Equivalence (TE) Code AB

18

Chartwell Pharmaceuticals llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 62505.

Regulatory Information RX

With a dosage strength EQ 100MG BASE

Dosage Form Route TABLET; ORAL

Reference Listed Drug No

Approved since 1984-09-11

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY